Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Warren

Showing results (1-10 of 256) with videos related to

Pageof 26
Sort By:
Clinical Medicine (London, England)|May 16, 2008
Medical dermatologyRichard B Warren
Expert Opinion on Biological Therapy|February 14, 2020
Ixekizumab for the treatment of psoriasis: up-to-dateSarah Craig, Richard B Warren
Dermatology and Therapy|December 4, 2013
Dermatology: future therapeutic perspectivesRichard B Warren, Alan Menter
Dermatology and Therapy|March 31, 2016
Erratum to: Letter from the EditorsAlan Menter, Richard B Warren
Lancet (London, England)|June 18, 2013
Ustekinumab for psoriatic arthritis: close to the PSUMMIT?Richard B Warren, Hector Chinoy
Expert Review of Clinical Immunology|February 9, 2013
Psoriasis and susceptibility to other autoimmune diseases: an outline for the clinicianFaisal R Ali, Richard B Warren
Expert Review of Clinical Immunology|March 24, 2011
Ustekinumab for the treatment of psoriasisPhilip M Laws, Richard B Warren
Immunotherapy|October 19, 2017
Guselkumab for psoriasis: a critical appraisal of Phase III studiesZenas Zn Yiu, Richard B Warren
Seminars in Cutaneous Medicine and Surgery|September 15, 2018
Ustekinumab for the treatment of psoriasis: an evidence updateZenas Zn Yiu, Richard B Warren
Current Problems in Dermatology|June 26, 2013
Patients' narrativesAmy C Foulkes, Richard B Warren
Pageof 26

Showing results (1-10 of 256) with videos related to

Sort By:
Pageof 26
Clinical Medicine (London, England)|May 16, 2008
Medical dermatologyRichard B Warren
Expert Opinion on Biological Therapy|February 14, 2020
Ixekizumab for the treatment of psoriasis: up-to-dateSarah Craig, Richard B Warren
Dermatology and Therapy|December 4, 2013
Dermatology: future therapeutic perspectivesRichard B Warren, Alan Menter
Dermatology and Therapy|March 31, 2016
Erratum to: Letter from the EditorsAlan Menter, Richard B Warren
Lancet (London, England)|June 18, 2013
Ustekinumab for psoriatic arthritis: close to the PSUMMIT?Richard B Warren, Hector Chinoy
Expert Review of Clinical Immunology|February 9, 2013
Psoriasis and susceptibility to other autoimmune diseases: an outline for the clinicianFaisal R Ali, Richard B Warren
Expert Review of Clinical Immunology|March 24, 2011
Ustekinumab for the treatment of psoriasisPhilip M Laws, Richard B Warren
Immunotherapy|October 19, 2017
Guselkumab for psoriasis: a critical appraisal of Phase III studiesZenas Zn Yiu, Richard B Warren
Seminars in Cutaneous Medicine and Surgery|September 15, 2018
Ustekinumab for the treatment of psoriasis: an evidence updateZenas Zn Yiu, Richard B Warren
Current Problems in Dermatology|June 26, 2013
Patients' narrativesAmy C Foulkes, Richard B Warren
Pageof 26